Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Corn pollen protein refers collectively to the diverse set of proteins present within maize (Zea mays) pollen. This group includes several well-characterized allergens—notably those designated by names such as Zea m 1 (expansin B family), Zea m 13, among others—which can trigger IgE-mediated allergic responses in susceptible individuals due to cross-reactivity with other grass pollens[2][3][6]. The major functional classes represented include enzymes involved in cell wall modification during fertilization processes—such as endoxylanases and beta-glucanases that facilitate penetration through stigma tissues—and structural/modulatory molecules like expansins that loosen plant cell walls during germination/pollination events [1][2]. Additionally, some corn pollen-derived peptide hydrolysates have demonstrated antioxidant and antimicrobial activities with potential nutraceutical applications [7]. However, because "corn pollen protein" is an umbrella term covering many different molecules rather than one defined target or receptor, it should not be treated as a single canonical therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corn pollen protein (CPP).